SPOP mutant subclass prediction and its impact on prostate cancer prognosis

被引：0
|
作者：
Liu, Deli
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-557
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
557
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prognostic value of the SPOP mutant genomic subclass in prostate cancer
    Shoag, Jonathan
    Liu, Deli
    Ma, Xiaoyue
    Oromendia, Clara
    Christos, Paul
    Ballman, Karla
    Angulo, Cynthia
    Cai, Peter Y.
    Gaffney, Christopher
    Klein, Eric
    Karnes, Jeffrey
    Den, Robert B.
    Liu, Yang
    Davicioni, Elai
    Barbieri, Christopher E.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (05) : 418 - 422
  • [2] IMPACT OF SPOP MUTATION ON PROSTATE CANCER PROGNOSIS
    Shoag, Jonathan
    Liu, Deli
    Ma, Xiayoue
    Oromendia, Clara
    Angulo, Cynthia
    Liu, Seagle
    Liu, Yang
    Davicioni, Elai
    Barbieri, Christopher
    JOURNAL OF UROLOGY, 2019, 201 (04): : E979 - E979
  • [3] Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer
    Liu, Deli
    Takhar, Mandeep
    Alshalalfa, Mohammed
    Erho, Nicholas
    Shoag, Jonathan
    Jenkins, Robert B.
    Karnes, R. Jeffrey
    Ross, Ashley E.
    Schaeffer, Edward M.
    Rubin, Mark A.
    Trock, Bruce
    Klein, Eric A.
    Den, Robert B.
    Tomlins, Scott A.
    Spratt, Daniel E.
    Davicioni, Elai
    Sboner, Andrea
    Barbieri, Christopher E.
    JCO PRECISION ONCOLOGY, 2018, 2 : 1 - 13
  • [4] SPOP MUTANT PROSTATE CANCER IS NOT DRIVEN BY ERG STABILIZATION
    Shoag, Jonathan
    Liu, Deli
    Blattner, Mirjam
    Sboner, Andrea
    Mosquera, Juan Miguel
    Robinson, Brian
    Chen, Yu
    Barbieri, Christopher
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1323 - E1323
  • [5] Clinical and genomic features of SPOP-mutant prostate cancer
    Nakazawa, Mari
    Fang, Mike
    Marshall, Catherine H.
    Lotan, Tamara L.
    Velho, Pedro Isaacsson
    Antonarakis, Emmanuel S.
    PROSTATE, 2022, 82 (02): : 260 - 268
  • [6] Quantification of mutant SPOP proteins in prostate cancer using targeted proteomics
    Wang, Hui
    Barbieri, Christopher
    He, Jintang
    Gao, Yuqian
    Wu, Chaochao
    Schepmoes, Athena
    Fillmore, Thomas
    Shi, Tujin
    Chae, Sung-Suk
    Huang, Dennis
    Mosquera, Juan Miguel
    Qian, Wei-Jun
    Smith, Richard
    Srivastava, Sudhir
    Kagan, Jacob
    Camp, David
    Rodland, Karin
    Rubin, Mark
    Liu, Tao
    CANCER RESEARCH, 2016, 76
  • [7] SPOP-mutant prostate cancer: Translating fundamental biology into patient care
    Bernasocchi, Tiziano
    Theurillat, Jean-Philippe P.
    CANCER LETTERS, 2022, 529 : 11 - 18
  • [8] Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer
    Theurillat, Jean-Philippe P.
    Udeshi, Namrata D.
    Errington, Wesley J.
    Svinkina, Tanya
    Baca, Sylvan C.
    Pop, Marius
    Wild, Peter J.
    Blattner, Mirjam
    Groner, Anna C.
    Rubin, Mark A.
    Moch, Holger
    Prive, Gilbert G.
    Carr, Steven A.
    Garraway, Levi A.
    SCIENCE, 2014, 346 (6205) : 85 - 89
  • [9] Analysis of ERG and SPOP subtypes in prostate cancer in the Colombian population and their possible implications on prognosis.
    Montero Ovalle, Wendy
    Segura Moreno, Yenifer
    Carolina Sanabria-Salas, Maria
    Lopez de Mesa, Jorge Mesa
    Varela Ramirez, Rodolfo
    Medina Boada, Vilma
    Serrano Lopez, Martha Lucia
    CANCER RESEARCH, 2021, 81 (13)
  • [10] Progress in Prognosis and Prediction for Men with Prostate Cancer
    Sundi, Debasish
    Schaeffer, Edward M.
    EUROPEAN UROLOGY, 2017, 72 (01) : 32 - 33
12345